Aptose Biosciences
APTO
#10464
Rank
NZ$7.54 M
Marketcap
NZ$2.96
Share price
0.00%
Change (1 day)
763.25%
Change (1 year)

Market capitalization of Aptose Biosciences (APTO)

Market cap: NZ$7.54 Million

As of December 2025 Aptose Biosciences has a market cap of NZ$7.54 Million. This makes Aptose Biosciences the world's 10464th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aptose Biosciences from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$7.54 M-70.74%
2024NZ$25.79 M-19.26%
2023NZ$31.94 M-65.7%
2022NZ$93.15 M-47.28%
2021NZ$0.17 B-67.28%
2020NZ$0.54 B-15.07%
2019NZ$0.63 B485.49%
2018NZ$0.10 B28.9%
2017NZ$84.25 M223.09%
2016NZ$26.07 M-42.89%
2015NZ$45.66 M-48.33%
2014NZ$88.37 M190.51%
2013NZ$30.41 M90.07%
2012NZ$16 M208.92%
2011NZ$5.18 M-73.99%
2010NZ$19.92 M-21.78%
2009NZ$25.46 M89.79%
2008NZ$13.41 M-73.43%
2007NZ$50.49 M-23.13%
2006NZ$65.69 M3.61%
2005NZ$63.4 M-56.19%
2004NZ$0.14 B-27.87%
2003NZ$0.20 B120.35%
2002NZ$91.06 M-66.82%
2001NZ$0.27 B-24.94%
2000NZ$0.36 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Aptose Biosciences was reported to be:

N/A
by Nasdaq info icon info icon
NZ$7.54 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Advaxis
ADXS
NZ$2.2 M-70.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
NZ$0.31 B 4,058.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
NZ$15.08 B 199,783.50%๐Ÿ‡บ๐Ÿ‡ธ USA